drugset / Trial / NCT03923322

Botanical Tincture for Symptoms of Irritable Bowel Syndrome

NCT03923322 ↗

Phase 2 Withdrawn Stamford Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The main purpose of this study is to investigate the feasibility of a follow-up larger RCT on the efficacy of Botanical Tincture to relieve abdominal pain in people with Irritable Bowel Syndrome Constipation Predominant (IBS-C).

Timeline

Start
2025-01
Primary completion
2025-01
Completion
2025-01

Outcome

Outcome not reported

Stopped: “Budget limitations”

Drugs

EvaluationDrugModalityDoseRoute
Subject Botanical Tincture Unknown 2.5 ml Oral